ACIP Presentation Slides: June 23-25, 2021 Meeting
On This Page
Note: These files are not yet 508
Slides will be added as they become available.
June 23, 2021
Welcome & Introductions
- Introduction
Dr. J Romero
Dr. A Cohn
Coronavirus Disease 2019 (COVID-19) Vaccines
- Introduction [14 pages]
Dr. M Daley
- Overview of myocarditis and pericarditis [12 pages]
Dr. M Oster - Update on COVID-19 vaccine safety, including myocarditis after mRNA vaccines [51 pages]
Dr. T Shimabukuro - VaST assessement [13 pages]
Dr. G Lee - COVID-19 mRNA vaccines in adolescents and young adults: benefit-risk discussion [44 pages]
Dr. M Wallace - Overview of data to inform recommendations for additional doses of COVID-19 vaccines [56 pages]
Dr. S Oliver
June 24, 2021
Welcome & Introductions
- Welcome and Introductions
Dr. J Romero
Dr. A Cohn
Dengue Vaccine
- Introduction [8 pages]
Dr. W Chen - Acceptability of dengue vaccine in Puerto Rico [31 pages]
Dr. I Esquilin - Implementation of dengue vaccine in Puerto Rico [28 pages]
Dr. I Cardona - Dengue vaccine draft recommendations using the evidence to recommendation framework [57 pages]
Dr. G Paz-Bailey - Dengue VFC Resolution [6 pages]
Dr. J Santoli
Influenza Vaccines
- Introduction [4 pages]
Dr. K Talbot - Flucelvax Quadrivalent (ccIIV4) Phase III Randomized Controlled Trial—Immunogenicity and Safety in Children 6 through 47 months [14 pages]
Dr. G Sylvester - Work group considerations and proposed recommendations for the 2021-22 Influenza Season [33 pages]
Dr. L Grohskopf - Updates to Influenza VFC Resolution
Dr. J Santoli
Rabies Vaccines
- Introduction [8 pages]
Dr. S Frey - Rabies immune globulin [20 pages]
Dr. A Rao - Rabies post-exposure prophylaxis schedule [25 pages]
Dr. A Rao - Rabies pre-exposure prophylaxis: GRADE/EtR summary [30 pages]
Dr. A Rao
June 25, 2021
Welcome & Introductions
- Welcome and Introductions
Dr. J Romero
Dr. A Cohn
Zoster Vaccine
- Introduction [8 pages]
Dr. G Lee - Burden of herpes zoster in immunocompromised adults [20 pages]
Dr. T Anderson - Use of recombinant zoster vaccine in immunocompromised populations: overview of clinical program [22 pages]
Dr. R Widenmaier
Pneumococcal Vaccine
- Introduction [14 pages]
Dr. K Poehling - Updates on epidemiology of invasive pneumococcal disease in U.S. adults [18 pages]
Dr. R Gierke - Cost effectiveness of PCV15 and PCV20 use in U.S. adults [31 pages]
Dr. C Stoecker - GRADE for age-based PCV15 and PCV20 use in U.S. adults [35 pages]
Dr. J Farrar - EtR summary of age-based PCV15 and PCV20 use in U.S. adults [97 pages]
Dr. M Kobayashi - Summary and timeline
Dr. M Kobayashi